BMS-599626
Code | Size | Price |
---|
TAR-T2610-2mg | 2mg | £121.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T2610-5mg | 5mg | £162.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T2610-1mL | 1 mL * 10 mM (in DMSO) | £305.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T2610-25mg | 25mg | £374.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T2610-50mg | 50mg | £461.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
BMS-599626 has been used in trials studying the treatment of Cancer, Metastases, and HER2 or EGFR Expressing Advanced Solid Malignancies.
CAS:
714971-09-2
Formula:
C27H27FN8O3
Molecular Weight:
530.55
Pathway:
Angiogenesis; Tyrosine Kinase/Adaptors; MAPK; JAK/STAT signaling
Purity:
0.98
SMILES:
Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4n(Cc5cccc(F)c5)ncc4c3)c12
Target:
EGFR; MEK; HER; Src
References
1. Wong TW, et al. Clin Cancer Res, 2006, 12(20 Pt 1), 6186-6193.
2. Torres MA, et al. Invest New Drugs, 2011, 29(4), 554-561.
3. Haluska P, et al. Mol Cancer Ther, 2008, 7(9), 2589-2598.